Publication | Closed Access

A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and β-amyloid plaques in a mouse model of Alzheimer＇s disease

VaccinationAlzheimer's DiseaseVaccine DevelopmentBehavioral ImpairmentImmunologyTherapeutic VaccineDegenerative PathologyNeurologyVaccine DesignMedicineVaccine ResearchMouse Modelβ-Amyloid Plaques